These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8806127)

  • 41. [Side effects and complications in the external use of corticosteroids in dermatologic practice].
    Babaiants RS; Konstantinov AV; Potekaev NS; Ivanov OL
    Vestn Dermatol Venerol; 1976 Feb; (2):13-7. PubMed ID: 936767
    [No Abstract]   [Full Text] [Related]  

  • 42. [Topical corticosteroids versus topical inhibitors of calcineurin].
    Niedner R
    Hautarzt; 2003 Apr; 54(4):338-41. PubMed ID: 12669205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical therapy for psoriasis.
    Lebwohl M; Abel E; Zanolli M; Koo J; Drake L
    Int J Dermatol; 1995 Oct; 34(10):673-84. PubMed ID: 8537153
    [No Abstract]   [Full Text] [Related]  

  • 44. [Which topical corticoid and how should it be used?].
    Harms M
    Rev Med Suisse Romande; 1990 Mar; 110(3):203-8. PubMed ID: 2336505
    [No Abstract]   [Full Text] [Related]  

  • 45. The use and abuse of topical corticosteroids.
    Catterall MD
    J R Nav Med Serv; 1977; 63(1):18-25. PubMed ID: 864627
    [No Abstract]   [Full Text] [Related]  

  • 46. Topical glucocorticoids. How they are used and misused.
    Fusaro RM; Kingsley DN
    Postgrad Med; 1986 Jan; 79(1):283-91. PubMed ID: 3941817
    [No Abstract]   [Full Text] [Related]  

  • 47. [Complications of local steroid therapy].
    de Graciansky P; Hincky JM
    Rev Prat; 1974 Apr; 24(23):2069-70, 2075-6, 2079-80 passim. PubMed ID: 4416935
    [No Abstract]   [Full Text] [Related]  

  • 48. Topical dermatologic therapy.
    McKay M
    Prim Care; 1983 Sep; 10(3):513-24. PubMed ID: 6556696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
    van de Kerkhof PC; Mrowietz U; Segaert S; Kragballe K
    Br J Dermatol; 2007 Apr; 156(4):771-2. PubMed ID: 17263798
    [No Abstract]   [Full Text] [Related]  

  • 50. [Topical corticosteroids].
    Duchesneau J; Grondin M
    Union Med Can; 1995 Mar; 124(1):15-9. PubMed ID: 8540145
    [No Abstract]   [Full Text] [Related]  

  • 51. Halcinonide (Halog)--another new topical steroid.
    Med Lett Drugs Ther; 1975 May; 17(11):46-7. PubMed ID: 1128441
    [No Abstract]   [Full Text] [Related]  

  • 52. Topical corticosteroids.
    Levine N
    Ariz Med; 1979 Dec; 36(12):904-8. PubMed ID: 518359
    [No Abstract]   [Full Text] [Related]  

  • 53. [Bronchial asthma and inflammatory dermatoses. Topical glucocorticoid treatment].
    Schäfer-Korting M; Korting HC
    Pharm Unserer Zeit; 2003; 32(4):306-13. PubMed ID: 12899068
    [No Abstract]   [Full Text] [Related]  

  • 54. Possible side effects of topical steroids.
    Morman MR
    Am Fam Physician; 1981 Feb; 23(2):171-4. PubMed ID: 6450525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Br J Dermatol; 1983 Jul; 109 Suppl 25():114-6. PubMed ID: 6860578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical dermatologic therapy in theory and in practice.
    Halliwell RE
    Tijdschr Diergeneeskd; 1986 Apr; 111 Suppl 1():76S-80S. PubMed ID: 3715844
    [No Abstract]   [Full Text] [Related]  

  • 57. Topical corticosteroids.
    Surber C; Itin PH; Bircher AJ; Maibach HI
    J Am Acad Dermatol; 1995 Jun; 32(6):1025-30. PubMed ID: 7751447
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical adverse effects in the use of corticosteroids on the skin (topical treatment)].
    Wereide K
    Tidsskr Nor Laegeforen; 1976 Nov; 92(33):1750-2. PubMed ID: 996843
    [No Abstract]   [Full Text] [Related]  

  • 59. Hot topic: updates on therapeutic approaches to inflammatory skin diseases: from molecular targets to drug development. Part II.
    Korkina L; Pastore S
    Curr Drug Metab; 2010 Jun; 11(5):407-8. PubMed ID: 20550515
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experience with using methosine in treating dermatoses].
    Samsonov VA; Ievleva EA; Nemenko AA
    Vestn Dermatol Venerol; 1974; 48(7):72-4. PubMed ID: 4608074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.